Why Executive Leadership Is Key to Reducing Denials
- Oct 3, 2025
- 2 min read
Updated: May 20
Claim denials cost U.S. healthcare providers billions of dollars annually, yet more than 80% are preventable. For healthcare executives, this represents both a critical challenge and a significant opportunity. Denial management is no longer just a billing function—it's a strategic imperative that requires executive-level attention and cross-departmental alignment.
Understanding the True Cost of Denials

The financial impact of denials extends far beyond immediate revenue loss. Consider a $50,000 surgical procedure denied due to missing prior authorization. Beyond the unbilled revenue, indirect costs accumulate rapidly: staff time spent on appeals, delayed cash flow impacting operations, potential bad debt if patients cannot pay, and opportunity costs of resources diverted from revenue-generating activities.
Industry benchmarks reveal that high-performing organizations maintain denial rates below 5%, while average performers often see rates between 8-12%. The difference between these tiers can translate to millions in recovered revenue.
The Strategic Role of Leadership
Reducing denials requires top-down commitment. When CFOs, COOs, and CMOs work together to align clinical priorities with financial goals, they create the foundation for sustainable improvement. Executives who view denials as strategic risks—not just operational nuisances—empower their teams to take meaningful action.
Leadership priorities should include:
Integrating denial metrics into executive dashboards
Reviewing denial trends at routine leadership meetings
Sponsoring interdepartmental denial prevention initiatives
Aligning incentives with quality and revenue performance
Establishing clear accountability structures with defined roles
Creating Cross-Departmental Alignment
One of the most effective strategies is implementing monthly "Denial Summits" where department heads present their denial trends, root cause analyses, and improvement plans. These sessions foster cross-departmental understanding and create peer accountability.
For example, when the Emergency Department experiences high denial rates due to incomplete documentation, the CMO can work with the ED Medical Director to implement point-of-care documentation tools and physician training programs. This collaborative approach addresses root causes rather than symptoms.
Measuring What Matters
What gets measured gets managed. Leaders must invest in denial reporting infrastructure that delivers both high-level trends and granular detail. Essential metrics include:
Overall denial rate and denial rate by payer, service line, and provider
First-pass resolution rate
Top 5 denial reasons by volume and dollar amount
Net collection rate of denied claims
Days in A/R attributable to denials
Time to resolution for appeals
Create visual dashboards that teams can review weekly. Share trends in leadership meetings. Use KPIs to inform bonus structures, budget requests, and staff coaching plans.
The ROI of Executive Engagement
Organizations with strong executive sponsorship of denial prevention initiatives consistently outperform their peers. RevCure's physician-led model empowers executive teams with proven, scalable solutions, with an average client ROI of 500% and over $17 million in recovered revenue across all payer types.
The most successful organizations don't wait for denials to indicate problems—they proactively monitor compliance, engage with payers collaboratively, and invest in the tools and training that prevent denials before they occur.
Taking Action
The time to act is now. Review your denial data. Engage your teams. Rethink your workflows. Lead your organization toward a more resilient and financially sustainable future—one clean claim at a time.
Success in denial prevention requires patience, persistence, and commitment to continuous improvement. The question isn't whether you can afford to invest in denial prevention—it's whether you can afford not to.
We can help. Reach out for your free Opportunity Audit anytime.




Comments